sodium oxybate
Generic: sodium oxybate
Labeler: camber pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
sodium oxybate
Generic Name
sodium oxybate
Labeler
camber pharmaceuticals, inc.
Dosage Form
SOLUTION
Routes
Active Ingredients
sodium oxybate .5 g/mL
Manufacturer
Identifiers & Regulatory
Product NDC
31722-891
Product ID
31722-891_cd5e0e58-4136-450e-b3bc-c63ffcfc1d94
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA210523
DEA Schedule
ciii
Listing Expiration
2027-12-31
Marketing Start
2026-01-01
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
31722891
Hyphenated Format
31722-891
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
sodium oxybate (source: ndc)
Generic Name
sodium oxybate (source: ndc)
Application Number
ANDA210523 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- .5 g/mL
Packaging
- 1 BOTTLE in 1 CARTON (31722-891-18) / 180 mL in 1 BOTTLE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "cd5e0e58-4136-450e-b3bc-c63ffcfc1d94", "openfda": {"upc": ["0331722891189"], "unii": ["7G33012534"], "rxcui": ["349482"], "spl_set_id": ["5dcf9a5c-312b-420b-82f3-42177d8f9ee4"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (31722-891-18) / 180 mL in 1 BOTTLE", "package_ndc": "31722-891-18", "marketing_start_date": "20260101"}], "brand_name": "sodium oxybate", "product_id": "31722-891_cd5e0e58-4136-450e-b3bc-c63ffcfc1d94", "dosage_form": "SOLUTION", "pharm_class": ["Central Nervous System Depressant [EPC]", "Central Nervous System Depression [PE]", "Decreased Central Nervous System Organized Electrical Activity [PE]"], "product_ndc": "31722-891", "dea_schedule": "CIII", "generic_name": "sodium oxybate", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "sodium oxybate", "active_ingredients": [{"name": "SODIUM OXYBATE", "strength": ".5 g/mL"}], "application_number": "ANDA210523", "marketing_category": "ANDA", "marketing_start_date": "20260101", "listing_expiration_date": "20271231"}